{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T20:01:20Z","timestamp":1782590480912,"version":"3.54.5"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2008,3,26]],"date-time":"2008-03-26T00:00:00Z","timestamp":1206489600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Surg Int"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1007\/s00383-008-2137-5","type":"journal-article","created":{"date-parts":[[2008,3,25]],"date-time":"2008-03-25T15:43:59Z","timestamp":1206459839000},"page":"521-530","source":"Crossref","is-referenced-by-count":52,"title":["Multiple endocrine neoplasia syndromes, children, Hirschsprung\u2019s disease and RET"],"prefix":"10.1007","volume":"24","author":[{"given":"S. W.","family":"Moore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. G.","family":"Zaahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,3,26]]},"reference":[{"issue":"2","key":"2137_CR1","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/01.pas.0000176432.73455.1b","volume":"30","author":"AJ Adeniran","year":"2006","unstructured":"Adeniran AJ, Zhu Z, Gandhi M, Steward DL, Fidler JP, Giordano TJ, Biddinger PW, Nikiforov YE (2006) Correlation between genetic alterations and microscopic features, clinical manifestations, and prognostic characteristics of thyroid papillary carcinomas. Am J Surg Pathol 30(2):216\u2013222","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"2137_CR2","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1006\/bbrc.2002.6731","volume":"292","author":"AA Akhand","year":"2002","unstructured":"Akhand AA, Ikeyama T, Akazawa S, Kato M, Hossain K, Takeda K, Suzuki H, Takahashi M, Nakashima I (2002) Evidence of both extra- and intracellular cysteine targets of protein modification for activation of RET kinase. Biochem Biophys Res Commun 292(4):826\u2013831","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"2137_CR3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ajmg.10399","volume":"110","author":"G Antinolo","year":"2002","unstructured":"Antinolo G, Marcos I, Fernandez RM, Romero M, Borrego S (2002) A novel germline point mutation, c.2304 G\u2013>T, in codon 768 of the RET proto-oncogene in a patient with medullary thyroid carcinoma. Am J Med Genet 110(1):85\u201387","journal-title":"Am J Med Genet"},{"issue":"4","key":"2137_CR4","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1210\/me.2003-0173","volume":"18","author":"E Arighi","year":"2004","unstructured":"Arighi E, Popsueva A, Degl\u2019Innocenti D, Borrello MG, Carniti C, Perala NM, Pierotti MA, Sariola H (2004) Biological effects of the dual phenotypic Janus mutation of ret cosegregating with both multiple endocrine neoplasia type 2 and Hirschsprung\u2019s disease. Mol Endocrinol 18(4):1004\u20131017","journal-title":"Mol Endocrinol"},{"issue":"3","key":"2137_CR5","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1128\/MCB.15.3.1613","volume":"15","author":"N Asai","year":"1995","unstructured":"Asai N, Iwashita T, Matsuyama M, Takahashi M (1995) Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations. Mol Cell Biol 15(3):1613\u20131619","journal-title":"Mol Cell Biol"},{"issue":"4","key":"2137_CR6","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1086\/302329","volume":"64","author":"A Auricchio","year":"1999","unstructured":"Auricchio A, Griseri P, Carpentieri ML, Betsos N, Staiano A, Tozzi A, Priolo M, Thompson H, Bocciardi R, Romeo G, Ballabio A, Ceccherini I (1999) Double heterozygosity for a RET substitution interfering with splicing and an EDNRB missense mutation in Hirschsprung disease. Am J Hum Genet 64(4):1216\u20131221","journal-title":"Am J Hum Genet"},{"issue":"1","key":"2137_CR7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/CCO.0b013e32801173ea","volume":"19","author":"DW Ball","year":"2007","unstructured":"Ball DW (2007) Medullary thyroid cancer: therapeutic targets and molecular markers.(Curr Opin Oncol 19(1):18\u201323","journal-title":"Curr Opin Oncol"},{"issue":"5","key":"2137_CR8","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0896-6273(03)00730-X","volume":"40","author":"A Barlow","year":"2003","unstructured":"Barlow A, de Graaff E, Pachnis V (2003) Enteric nervous system progenitors are coordinately controlled by the G protein-coupled receptor EDNRB and the receptor tyrosine kinase RET. Neuron 40(5):905\u2013916","journal-title":"Neuron"},{"key":"2137_CR9","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1001\/jama.1978.03290140046020","volume":"240","author":"E Blank","year":"1978","unstructured":"Blank E, Neerhout RC, Burry KA (1978) Congenital mesoblastic nephroma and polyhydramnios. JAMA 240:1504\u20131505","journal-title":"JAMA"},{"issue":"9","key":"2137_CR10","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1002\/(SICI)1097-0142(19961101)78:9<1996::AID-CNCR22>3.0.CO;2-S","volume":"78","author":"RD Blank","year":"1996","unstructured":"Blank RD, Sklar CA, Dimich AB, LaQuaglia MP, Brennan MF (1996) Clinical presentations and RET protooncogene mutations in seven multiple endocrine neoplasia type 2 kindreds. Cancer 78(9):1996\u20132003","journal-title":"Cancer"},{"key":"2137_CR11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0046-8177(74)80021-3","volume":"5","author":"RP Bolande","year":"1974","unstructured":"Bolande RP (1974) The neurocristopathies, a unifying concept of disease arising in neural crest maldevelopment. Hum Pathol 5:409\u2013429","journal-title":"Hum Pathol"},{"issue":"1","key":"2137_CR12","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1073\/pnas.97.1.268","volume":"97","author":"S Bolk","year":"2000","unstructured":"Bolk S, Pelet A, Hofstra RM, Angrist M, Salomon R, Croaker D, Buys CH, Lyonnet S, Chakravarti A (2000) A human model for multigenic inheritance: phenotypic expression in Hirschsprung disease requires both the RET gene and a new 9q31 locus. Proc Natl Acad Sci USA 97(1):268\u2013273","journal-title":"Proc Natl Acad Sci USA"},{"key":"2137_CR13","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1055\/s-2008-1066521","volume":"6","author":"JP Bonnet","year":"1996","unstructured":"Bonnet JP, Till M, Edery P, Attie T, Lyonnet S (1996) Waardenburg-Hirschsprung disease in two sisters: a possible clue to the genetics of this association. Eur J Pediatr Surg 6:245\u2013248","journal-title":"Eur J Pediatr Surg"},{"issue":"11","key":"2137_CR14","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1089\/105072502320908367","volume":"12","author":"S Borrego","year":"2002","unstructured":"Borrego S, Fernandez RM, Dziema H, Japon MA, Marcos I, Eng C, Antinolo G (2002) Evaluation of germline sequence variants of GFRA1, GFRA2, and GFRA3 genes in a cohort of Spanish patients with sporadic medullary thyroid cancer. Thyroid 12(11):1017\u20131022","journal-title":"Thyroid"},{"issue":"9","key":"2137_CR15","first-page":"3361","volume":"83","author":"S Borrego","year":"1998","unstructured":"Borrego S, Eng C, Sanchez B, Saez ME, Navarro E, Antinolo G (1998) Molecular analysis of the ret and GDNF genes in a family with multiple endocrine neoplasia type 2A and Hirschsprung disease. J Clin Endocrinol Metab 83(9):3361\u20133364","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2137_CR16","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1136\/jmg.40.3.e18","volume":"40","author":"S Borrego","year":"2003","unstructured":"Borrego S, Fernandez RM, Dziema H, Niess A, Lopez-Alonso M, Antinolo G, Eng C (2003) Investigation of germline GFRA4 mutations and evaluation of the involvement of GFRA1, GFRA2, GFRA3, and GFRA4 sequence variants in Hirschsprung disease. J Med Genet 40(3):e18","journal-title":"J Med Genet"},{"issue":"4","key":"2137_CR17","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0039-6060(05)80057-1","volume":"117","author":"MJ Borst","year":"1995","unstructured":"Borst MJ, VanCamp JM, Peacock ML, Decker RA (1995) Mutational analysis of multiple endocrine neoplasia type 2A associated with Hirschsprung\u2019s disease. Surgery 117(4):386\u2013391","journal-title":"Surgery"},{"issue":"12","key":"2137_CR18","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","volume":"86","author":"ML Brandi","year":"2001","unstructured":"Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P et al (2001) Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86(12):5658\u20135671","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2137_CR19","first-page":"485","volume":"36","author":"AS Brooks","year":"1999","unstructured":"Brooks AS, Breuning MH, Osinga J, vd Smagt JJ, Catsman CE, Buys CH, Meijers C, Hofstra RM (1999) A consanguineous family with Hirschsprung disease, microcephaly, and mental retardation (Goldberg-Shprintzen syndrome). J Med Genet 36(6):485\u2013489","journal-title":"J Med Genet"},{"issue":"8","key":"2137_CR20","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/sj.ejhg.5201199","volume":"12","author":"GM Burzynski","year":"2004","unstructured":"Burzynski GM, Nolte IM, Osinga J, Ceccherini I, Twigt B, Maas S, Brooks A, Verheij J, Plaza Menacho I, Buys CH, Hofstra RM (2004) Localizing a putative mutation as the major contributor to the development of sporadic Hirschsprung disease to the RET genomic sequence between the promoter region and exon 2. Eur J Hum Genet 12(8):604\u2013612","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"2137_CR21","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jpedsurg.2006.09.019","volume":"42","author":"A Butter","year":"2007","unstructured":"Butter A, Gagne J, Al Jazaeri A, Emran MA, Deal C, St Vil D (2007) Prophylactic thyroidectomy in pediatric carriers of multiple endocrine neoplasia type 2A or familial medullary thyroid carcinoma: mutation in C620 is associated with Hirschsprung\u2019s disease. J Pediatr Surg 42(1):203\u2013206","journal-title":"J Pediatr Surg"},{"issue":"11","key":"2137_CR22","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1002\/j.1460-2075.1996.tb00632.x","volume":"15","author":"F Carlomagno","year":"1996","unstructured":"Carlomagno F, De Vita G, Berlingieri MT, de Franciscis V, Melillo RM, Colantuoni V, Kraus MH, Di Fiore PP, Fusco A, Santoro M (1996) Molecular heterogeneity of RET loss of function in Hirschsprung\u2019s disease. EMBO J 15(11):2717\u20132725","journal-title":"EMBO J"},{"issue":"3","key":"2137_CR23","first-page":"391","volume":"57","author":"F Carlomagno","year":"2006","unstructured":"Carlomagno F, Salvatore G, Cirafici AM, De Vita G, Melillo RM, de Franciscis V, Billaud M, Fusco A, Santoro M (2006) The different RET-activating capability of mutations of cysteine 620 or cysteine 634 correlates with the multiple endocrine neoplasia type 2 disease phenotype. Cancer Res 57(3):391\u2013395","journal-title":"Cancer Res"},{"issue":"6","key":"2137_CR24","first-page":"1076","volume":"55","author":"KM Carlson","year":"1994","unstructured":"Carlson KM, Bracamontes J, Jackson CE, Clark R, Lacroix A, Wells SA Jr, Goodfellow PJ (1994) Parent-of-origin effects in multiple endocrine neoplasia type 2B. Am J Hum Genet 55(6):1076\u20131082","journal-title":"Am J Hum Genet"},{"issue":"7","key":"2137_CR25","first-page":"2731","volume":"81","author":"P Caron","year":"1996","unstructured":"Caron P, Attie T, David D, Amiel J, Brousset F, Roger P, Munnich A, Lyonnet S (1996) C618R mutation in exon 10 of the RET proto-oncogene in a kindred with multiple endocrine neoplasia type 2A and Hirschsprung\u2019s disease. J Clin Endocrinol Metab 81(7):2731\u20132733","journal-title":"J Clin Endocrinol Metab"},{"issue":"22","key":"2137_CR26","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1038\/sj.onc.1202202","volume":"17","author":"S Chappuis-Flament","year":"1998","unstructured":"Chappuis-Flament S, Pasini A, De Vita G, Segouffin-Cariou C, Fusco A, Attie T, Lenoir GM, Santoro M, Billaud M (1998) Dual effect on the RET receptor of MEN2 mutations affecting specific extracytoplasmic cysteines. Oncogene 17(22):2851\u20132861","journal-title":"Oncogene"},{"issue":"2","key":"2137_CR27","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/bies.20357","volume":"28","author":"F Costantini","year":"2006","unstructured":"Costantini F, Shakya R. (2006) GDNF\/Ret signaling and the development of the kidney. Bioessays 28(2):117\u2013127","journal-title":"Bioessays"},{"issue":"6","key":"2137_CR28","first-page":"311","volume":"150","author":"JW Groot de","year":"2006","unstructured":"de Groot JW, Links TP, Rouwe CW, van der Wal JE, Hofstra RM, Plukker JT (2006) Prophylactic thyroidectomy in children who are carriers of a multiple endocrine neoplasia type 2 mutation: description of 20 cases and recommendations based on the literature. Ned Tijdschr Geneeskd 150(6):311\u2013318","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"2","key":"2137_CR29","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0022-3468(98)90433-X","volume":"33","author":"RA Decker","year":"1998","unstructured":"Decker RA, Peacock ML (1998) Occurrence of MEN2a in familial Hirschsprung\u2019s disease: a new indication for genetic testing of the RET proto-oncogene. J Pediatr Surg 33(2):207\u2013214","journal-title":"J Pediatr Surg"},{"issue":"1","key":"2137_CR30","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/hmg\/7.1.129","volume":"7","author":"RA Decker","year":"1998","unstructured":"Decker RA, Peacock ML, Watson P (1998) Hirschsprung disease in MEN2A: increased spectrum of RET exon 10 genotypes and strong genotype-phenotype correlation. Hum Mol Genet 7(1):129\u2013134","journal-title":"Hum Mol Genet"},{"issue":"7","key":"2137_CR31","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/hmg\/2.7.851","volume":"2","author":"H Donis-Keller","year":"1993","unstructured":"Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K, Lairmore TC, Howe JR, Moley JF, Goodfellow P, Wells SA Jr (1993) Mutations in the RET proto-oncogene are associated with MEN2A and FMTC. Hum Mol Genet 2(7):851\u2013856","journal-title":"Hum Mol Genet"},{"issue":"6","key":"2137_CR32","first-page":"698","volume":"255","author":"H Dralle","year":"2004","unstructured":"Dralle H, Ukkat J, Brauckhoff M, Gimm O, Machens A (2004) Consortia experiences\u2014can we cure MTC? J Intern Med 255(6):698\u2013699","journal-title":"J Intern Med"},{"issue":"7","key":"2137_CR33","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00109-003-0455-6","volume":"81","author":"M Drosten","year":"2003","unstructured":"Drosten M, Putzer BM (2003) Gene therapeutic approaches for medullary thyroid carcinoma treatment. J Mol Med 81(7):411\u2013419","journal-title":"J Mol Med"},{"issue":"6","key":"2137_CR34","doi-asserted-by":"crossref","first-page":"e1-6","DOI":"10.1016\/j.jpedsurg.2005.03.031","volume":"40","author":"S Dvorakova","year":"2005","unstructured":"Dvorakova S, Dvorakova K, Malikova M, Skaba R, Vlcek P, Bendlova B. (2005) A novel Czech kindred with familial medullary thyroid carcinoma and Hirschsprung\u2019s disease. J Pediatr Surg 40(6):e1-6","journal-title":"J Pediatr Surg"},{"key":"2137_CR35","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/367378a0","volume":"367","author":"P Edery","year":"1994","unstructured":"Edery P, Lyonnet S, Mulligan L et al (1994) Mutations of the RET proto-oncogene in Hirschsprung\u2019s disease. Nature 367:378\u2013380","journal-title":"Nature"},{"issue":"3","key":"2137_CR36","first-page":"509","volume":"10","author":"C Eng","year":"1995","unstructured":"Eng C, Smith DP, Mulligan LM, Healey CS, Zvelebil MJ, Stonehouse TJ, Ponder MA, Jackson CE, Waterfield MD, Ponder BA (1995) A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC. Oncogene 10(3):509\u2013513","journal-title":"Oncogene"},{"issue":"2","key":"2137_CR37","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/hmg\/3.2.237","volume":"3","author":"C Eng","year":"1994","unstructured":"Eng C, Smith DP, Mulligan LM, Nagai MA, Healey CS, Ponder MA, Gardner E, Scheumann GF, Jackson CE, Tunnacliffe A, et al (1994) Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours. Hum Mol Genet 3(2):237\u2013241","journal-title":"Hum Mol Genet"},{"issue":"5","key":"2137_CR38","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/humu.10273","volume":"22","author":"RM Fernandez","year":"2003","unstructured":"Fernandez RM, Antinolo G, Eng C, Borrego S (2003) The RET C620S mutation causes multiple endocrine neoplasia type 2A (MEN2A) but not Hirschsprung disease (HSCR) in a family cosegregating both phenotypes. Hum Mutat 22(5):412\u2013415","journal-title":"Hum Mutat"},{"issue":"5","key":"2137_CR39","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/humu.10273","volume":"22","author":"RM Fernandez","year":"2003","unstructured":"Fernandez RM, Antinolo G, Eng C, Borrego S (2003) The RET C620S mutation causes multiple endocrine neoplasia type 2A (MEN2A) but not Hirschsprung disease (HSCR) in a family cosegregating both phenotypes. Hum Mutat 22(5):412\u2013415","journal-title":"Hum Mutat"},{"issue":"6","key":"2137_CR40","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1055\/s-2004-821209","volume":"14","author":"G Fitze","year":"2004","unstructured":"Fitze G (2004) Management of patients with hereditary medullary thyroid carcinoma. Eur J Pediatr Surg 14(6):375\u2013383","journal-title":"Eur J Pediatr Surg"},{"issue":"5","key":"2137_CR41","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1055\/s-2004-44902","volume":"216","author":"G Fitze","year":"2004","unstructured":"Fitze G, Saeger HD, Roesner D, Schackert HK (2004) Management of multiple endocrine neoplasia syndrome type 2 families in association with rare germline mutations of the RET proto-oncogene. Klin Padiatr 216(5):270\u2013276","journal-title":"Klin Padiatr"},{"issue":"2","key":"2137_CR42","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1530\/eje.1.02216","volume":"155","author":"K Frank-Raue","year":"2006","unstructured":"Frank-Raue K, Buhr H, Dralle H, Klar E, Senninger N, Weber T, Rondot S, Hoppner W, Raue F (2006) Long-term outcome in 46 gene carriers of hereditary medullary thyroid carcinoma after prophylactic thyroidectomy: impact of individual RET genotype. Eur J Endocrinol 155(2):229\u2013236","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"2137_CR43","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1093\/hmg\/8.11.1989","volume":"8","author":"O Geneste","year":"1999","unstructured":"Geneste O, Bidaud C, De Vita G, Hofstra RM, Tartare-Deckert S, Buys CH, Lenoir GM, Santoro M, Billaud M (1999) Two distinct mutations of the RET receptor causing Hirschsprung\u2019s disease impair the binding of signalling effectors to a multifunctional docking site. Hum Mol Genet 8(11):1989\u20131999","journal-title":"Hum Mol Genet"},{"issue":"3","key":"2137_CR44","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/(SICI)1097-0142(19970201)79:3<564::AID-CNCR20>3.0.CO;2-0","volume":"79","author":"FD Gilliland","year":"1997","unstructured":"Gilliland FD, Hunt WC, Morris DM, Key CR (1997) Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973\u20131991. Cancer 79(3):564\u2013573","journal-title":"Cancer"},{"issue":"12","key":"2137_CR45","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1007\/s00268-004-7640-9","volume":"28","author":"O Gimm","year":"2004","unstructured":"Gimm O, Ukkat J, Niederle BE, Weber T, Thanh PN, Brauckhoff M, Niederle B, Dralle H (2004) Timing and extent of surgery in patients with familial medullary thyroid carcinoma\/multiple endocrine neoplasia 2A-related RET mutations not affecting codon 634. World J Surg 28(12):1312\u20131316","journal-title":"World J Surg"},{"issue":"2","key":"2137_CR46","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/humu.20135","volume":"25","author":"P Griseri","year":"2005","unstructured":"Griseri P, Bachetti T, Puppo F, Lantieri F, Ravazzolo R, Devoto M, Ceccherini I (2005) A common haplotype at the 5\u2032 end of the RET proto-oncogene, overrepresented in Hirschsprung patients, is associated with reduced gene expression. Hum Mutat 25(2):189\u2013195","journal-title":"Hum Mutat"},{"key":"2137_CR47","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1196\/annals.1353.025","volume":"1073","author":"TS Gujral","year":"2006","unstructured":"Gujral TS, Mulligan LM (2006) Molecular implications of RET mutations for pheochromocytoma risk in multiple endocrine neoplasia 2. Ann NY Acad Sci 1073:234\u2013240","journal-title":"Ann NY Acad Sci"},{"issue":"3","key":"2137_CR48","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0003-4266(06)72585-9","volume":"67","author":"S Guyetant","year":"2006","unstructured":"Guyetant S, Blechet C, Saint-Andre JP (2006) C-cell hyperplasia. Ann.Endocrinol (Paris) 67(3):190\u2013197","journal-title":"Ann.Endocrinol (Paris)"},{"key":"2137_CR49","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1210\/jcem-19-1-152","volume":"19","author":"JB Hazard","year":"1959","unstructured":"Hazard JB, Hawk WA, Crile G Jnr (1959) Medullary (solid) carcinoma of the thyroid:a clinicopathologic entity. J Clin Endocrinol Metab 19:152\u2013161","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2137_CR50","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/S0022-3468(99)90128-8","volume":"34","author":"K Inoue","year":"1999","unstructured":"Inoue K, Shimotake T, Inoue K, Tokiwa K (1999) Mutational analysis of the RET proto-oncogene in a kindred with multiple endocrine neoplasia type 2A and Hirschsprung\u2019s disease. J Pediatr Surg 34(10):1552\u20131554","journal-title":"J Pediatr Surg"},{"issue":"14","key":"2137_CR51","first-page":"2870","volume":"57","author":"S Ito","year":"1997","unstructured":"Ito S, Iwashita T, Asai N, Murakami H, Iwata Y, Sobue G, Takahashi M (1997) Biological properties of Ret with cysteine mutations correlate with multiple endocrine neoplasia type 2A, familial medullary thyroid carcinoma, and Hirschsprung\u2019s disease phenotype. Cancer Res 57(14):2870\u20132872","journal-title":"Cancer Res"},{"issue":"10","key":"2137_CR52","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1093\/hmg\/5.10.1577","volume":"5","author":"T Iwashita","year":"1996","unstructured":"Iwashita T, Murakami H, Asai N, Takahashi M (1996) Mechanism of ret dysfunction by Hirschsprung mutations affecting its extracellular domain. Hum Mol Genet 5(10):1577\u20131580","journal-title":"Hum Mol Genet"},{"issue":"4","key":"2137_CR53","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s11864-000-0052-7","volume":"1","author":"E Kebebew","year":"2000","unstructured":"Kebebew E, Clark OH (2000) Medullary thyroid cancer. Curr Treat Options.Oncol 1(4):359\u2013367","journal-title":"Curr Treat Options.Oncol"},{"key":"2137_CR54","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0022-3468(87)80612-7","volume":"22","author":"AH Khan","year":"1987","unstructured":"Khan AH, Desjardin JG, Gregoire H, Seidman E (1987) Gastrointestinal manifestations of the Sipple syndrome in children. J Pediatr Surg 22:719\u2013723","journal-title":"J Pediatr Surg"},{"issue":"48","key":"2137_CR55","doi-asserted-by":"crossref","first-page":"47898","DOI":"10.1074\/jbc.M309772200","volume":"278","author":"S Kjaer","year":"2003","unstructured":"Kjaer S, Ibanez CF (2003) Identification of a surface for binding to the GDNF-GFR alpha 1 complex in the first cadherin-like domain of RET. J Biol Chem 278(48):47898\u201347904","journal-title":"J Biol Chem"},{"issue":"44","key":"2137_CR56","doi-asserted-by":"crossref","first-page":"33577","DOI":"10.1074\/jbc.M605604200","volume":"281","author":"PP Knowles","year":"2006","unstructured":"Knowles PP, Murray-Rust J, Kjaer S, Scott RP, Hanrahan S, Santoro M, Ibanez CF, McDonald NQ (2006) Structure and chemical inhibition of the RET tyrosine kinase domain. J Biol Chem 281(44):33577\u201333587","journal-title":"J Biol Chem"},{"issue":"Pt 1","key":"2137_CR57","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1529-8817.2005.00196.x","volume":"70","author":"F Lantieri","year":"2006","unstructured":"Lantieri F, Griseri P, Puppo F, Campus R, Martucciello G, Ravazzolo R, Devoto M, Ceccherini I. (2006) Haplotypes of the human RET proto-oncogene associated with Hirschsprung disease in the Italian population derived from a single ancestral combination of alleles. Ann Hum Genet 70(Pt 1):12\u201326","journal-title":"Ann Hum Genet"},{"key":"2137_CR58","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1159\/000472371","volume":"2","author":"Y Luo","year":"1994","unstructured":"Luo Y, Barone V, Seri M, Bolino A, Bocciardi R, Ceccherini I, Pasini B, Tocco T, Lerone M, Cywes S, Moore S, Vanderwinden JM, Abramowicz MJ, Kristofferson U, Hamel B, Martucciello G, Romeo G (1994) Heterogeneity of mutations of the RET proto-oncogene in autosomal dominant HSCR. Eur J Hum Genet 2:272\u2013280","journal-title":"Eur J Hum Genet"},{"key":"2137_CR59","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1093\/hmg\/2.11.1803","volume":"2","author":"Y Luo","year":"1993","unstructured":"Luo Y, Ceccherini I, Pasini B, et al (1993) Close linkage with the RET proto-oncogene and boundaries of deletion mutations in autosomal dominant Hirschsprung disease. Hum Mol Genet. 2:1803\u20131808","journal-title":"Hum Mol Genet."},{"issue":"4","key":"2137_CR60","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1210\/jc.2004-1836","volume":"90","author":"A Machens","year":"2005","unstructured":"Machens A, Schneyer U, Holzhausen HJ, Dralle H (2005) Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level. J Clin Endocrinol Metab 90(4):2029\u20132034","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2137_CR61","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.surg.2005.07.034","volume":"139","author":"A Machens","year":"2006","unstructured":"Machens A, Dralle H (2006) DNA-based window of opportunity for curative pre-emptive therapy of hereditary medullary thyroid cancer. Surgery 139(3):279\u2013282","journal-title":"Surgery"},{"issue":"1\u20132","key":"2137_CR62","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.mce.2005.10.028","volume":"247","author":"A Machens","year":"2006","unstructured":"Machens A, Dralle H (2006) Multiple endocrine neoplasia type 2 and the RET protooncogene: from bedside to bench to bedside. Mol Cell Endocrinol 247(1\u20132):34\u201340","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"2137_CR63","first-page":"1104","volume":"86","author":"A Machens","year":"2001","unstructured":"Machens A, Gimm O, Hinze R, Hoppner W, Boehm BO, Dralle H (2001) Genotype\u2013phenotype correlations in hereditary medullary thyroid carcinoma: oncological features and biochemical properties. J Clin Endocrinol Metab 86(3):1104\u20131109","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2137_CR64","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1067\/S0039-6060(03)00157-0","volume":"134","author":"A Machens","year":"2003","unstructured":"Machens A, Holzhausen HJ, Thanh PN, Dralle H (2003) Malignant progression from C-cell hyperplasia to medullary thyroid carcinoma in 167 carriers of RET germline mutations. Surgery 134(3):425\u2013431","journal-title":"Surgery"},{"issue":"1","key":"2137_CR65","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2796.2004.01423.x","volume":"257","author":"A Machens","year":"2005","unstructured":"Machens A, Ukkat J, Brauckhoff M, Gimm O, Dralle H (2005) Advances in the management of hereditary medullary thyroid cancer. J Inter Med 257(1):50\u201359","journal-title":"J Inter Med"},{"issue":"4","key":"2137_CR66","first-page":"308","volume":"7","author":"G Martuciello","year":"1992","unstructured":"Martuciello G, Bicocci MP, Dodero P, Lerone M, Silengo-Cirillo M, Puliti A, Gimelli G (1992) Total colonic aganglionosis associated with intestitial deletion of the long arm of chromosome 10. Pediatr Surg Int 7(4):308\u2013310","journal-title":"Pediatr Surg Int"},{"issue":"2","key":"2137_CR67","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jpedsurg.2006.10.005","volume":"42","author":"SW Moore","year":"2007","unstructured":"Moore SW, Appfelstaedt J, Zaahl MG (2007) Familial medullary carcinoma prevention, risk evaluation, and RET in children of families with MEN2. J Pediatr Surg 42(2):326\u2013332","journal-title":"J Pediatr Surg"},{"issue":"2","key":"2137_CR68","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jpedsurg.2006.10.005","volume":"42","author":"SW Moore","year":"2007","unstructured":"Moore SW, Appfelstaedt J, Zaahl MG (2007) Familial medullary carcinoma prevention, risk evaluation, and RET in children of families with MEN2. J.Pediatr.Surg 42(2):326\u2013332","journal-title":"J.Pediatr.Surg"},{"issue":"6","key":"2137_CR69","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/hmg\/3.6.1007","volume":"3","author":"LM Mulligan","year":"1994","unstructured":"Mulligan LM, Eng C, Healey CS, Ponder MA, Feldman GL, Li P, Jackson CE, Ponder BA. (1994) A de novo mutation of the RET proto-oncogene in a patient with MEN2A. Hum Mol Genet 3(6):1007\u20131008","journal-title":"Hum Mol Genet"},{"issue":"6428","key":"2137_CR70","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/363458a0","volume":"363","author":"LM Mulligan","year":"1993","unstructured":"Mulligan LM, Kwok JB, Healey CS, Elsdon MJ, Eng C, Gardner E, Love DR, Mole SE, Moore JK, Papi L et al (1993) Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363(6428):458\u2013460","journal-title":"Nature"},{"issue":"4","key":"2137_CR71","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2796.1995.tb01208.x","volume":"238","author":"LM Mulligan","year":"1995","unstructured":"Mulligan LM, Marsh DJ, Robinson BG, Schuffenecker I, Zedenius J, Lips CJ, Gagel RF, Takai SI, Noll WW, Fink M et al (1995) Genotype\u2013phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium. J Intern Med 238(4):343\u2013346","journal-title":"J Intern Med"},{"issue":"2","key":"2137_CR72","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0039-6060(97)90028-3","volume":"122","author":"PB Musholt","year":"1997","unstructured":"Musholt PB, Musholt TJ, Goodfellow PJ, Zehnbauer BA, Wells SA, Moley JF (1997) \u201cCold\u201d single-strand conformational variants for mutation analysis of the RET proto-oncogene. Surgery 122(2):363\u2013370","journal-title":"Surgery"},{"issue":"9","key":"2137_CR73","first-page":"1690","volume":"57","author":"YE Nikiforov","year":"1997","unstructured":"Nikiforov YE, Rowland JM, Bove KE, Monforte-Munoz H, Fagin JA (1997) Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children. Cancer Res. 57(9):1690\u20131694","journal-title":"Cancer Res."},{"issue":"5","key":"2137_CR74","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/sj.ejhg.5200971","volume":"11","author":"M Nishikawa","year":"2003","unstructured":"Nishikawa M, Murakumo Y, Imai T, Kawai K, Nagaya M, Funahashi H, Takahashi M (2003) Cys611Ser mutation in RET proto-oncogene in a kindred with medullary thyroid carcinoma and Hirschsprung\u2019s disease. Eur J Hum Genet 11(5):364\u2013368","journal-title":"Eur J Hum Genet"},{"issue":"10","key":"2137_CR75","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.jpedsurg.2005.05.041","volume":"40","author":"MP Pakarinen","year":"2005","unstructured":"Pakarinen MP, Rintala RJ, Koivusalo A, Heikkinen M, Lindahl H, Pukkala E (2005) Increased incidence of medullary thyroid carcinoma in patients treated for Hirschsprung\u2019s disease. J Pediatr Surg 40(10):1532\u20131534","journal-title":"J Pediatr Surg"},{"issue":"4","key":"2137_CR76","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1067\/msy.2002.121093","volume":"131","author":"B Pasini","year":"2002","unstructured":"Pasini B, Rossi R, Ambrosio MR, Zatelli MC, Gullo M, Gobbo M, Collini P, Pansini G, Trasforini G, degli Uberti EC (2002) RET mutation profile and variable clinical manifestations in a family with multiple endocrine neoplasia type 2A and Hirschsprung\u2019s disease. Surgery 131(4):373\u2013381","journal-title":"Surgery"},{"key":"2137_CR77","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJM196701192760303","volume":"276","author":"E Passarge","year":"1967","unstructured":"Passarge E (1967) The genetics of Hirschsprung\u2019s disease. N Engl J Med 276:138\u2013143","journal-title":"N Engl J Med"},{"issue":"20","key":"2137_CR78","doi-asserted-by":"crossref","first-page":"7351","DOI":"10.1128\/MCB.22.20.7351-7363.2002","volume":"22","author":"G Pelicci","year":"2002","unstructured":"Pelicci G, Troglio F, Bodini A, Melillo RM, Pettirossi V, Coda L, De Giuseppe A, Santoro M, Pelicci PG (2002) The neuron-specific Rai (ShcC) adaptor protein inhibits apoptosis by coupling Ret to the phosphatidylinositol 3-kinase\/Akt signaling pathway. Mol Cell Biol 22(20):7351\u20137363","journal-title":"Mol Cell Biol"},{"issue":"2","key":"2137_CR79","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/(SICI)1098-1004(1997)10:2<155::AID-HUMU7>3.0.CO;2-J","volume":"10","author":"H Peretz","year":"1997","unstructured":"Peretz H, Luboshitsky R, Baron E, Biton A, Gershoni R, Usher S, Grynberg E, Yakobson E, Lapidot M (1997) Cys 618 Arg mutation in the RET proto-oncogene associated with familial medullary thyroid carcinoma and maternally transmitted Hirschsprung\u2019s disease suggesting a role for imprinting. Hum Mutat 10(2):155\u2013159","journal-title":"Hum Mutat"},{"issue":"4","key":"2137_CR80","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.bcp.2006.05.002","volume":"72","author":"G Petrangolini","year":"2006","unstructured":"Petrangolini G, Cuccuru G, Lanzi C, Tortoreto M, Belluco S, Pratesi G, Cassinelli G, Zunino F (2006) Apoptotic cell death induction and angiogenesis inhibition in large established medullary thyroid carcinoma xenografts by Ret inhibitor RPI-1. Biochem Pharmacol 72(4):405\u2013414","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"2137_CR81","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ng0298-171","volume":"18","author":"V Pingault","year":"1998","unstructured":"Pingault V, Bondurand N, Kuhlbrodt K, Goerich DE, Prehu MO, Puliti A, Herbarth B, Hermans-Borgmeyer I, Legius E, Matthijs G, Amiel J, Lyonnet S, Ceccherini I, Romeo G, Smith JC, Read AP, Wegner M, Goossens M (1998) SOX10 mutations in patients with Waardenburg-Hirschsprung disease. Nat Genet 18(2):171\u2013173","journal-title":"Nat Genet"},{"issue":"2","key":"2137_CR82","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1089\/thy.2006.0198","volume":"17","author":"G Pinna","year":"2007","unstructured":"Pinna G, Orgiana G, Riola A, Ghiani M, Lai ML, Carcassi C, Mariotti S (2007) RET proto-oncogene in Sardinia: V804M is the most frequent mutation and may be associated with FMTC\/MEN-2A phenotype. Thyroid 17(2):101\u2013104","journal-title":"Thyroid"},{"issue":"4","key":"2137_CR83","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1515\/JPEM.1994.7.4.373","volume":"7","author":"Y Rakover","year":"1994","unstructured":"Rakover Y, Dharan M, Luboshitsky R (1994) Hirschsprung\u2019s disease associated with isolated familial medullary carcinoma of the thyroid. J Pediatr Endocrinol 7(4):373\u2013377","journal-title":"J Pediatr Endocrinol"},{"issue":"6","key":"2137_CR84","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1046\/j.1365-2796.1998.00332.x","volume":"243","author":"G Romeo","year":"1998","unstructured":"Romeo G, Ceccherini I, Celli J, Priolo M, Betsos N, Bonardi G, Seri M, Yin L, Lerone M, Jasonni V, Martucciello G (1998) Association of multiple endocrine neoplasia type 2 and Hirschsprung disease. J Intern Med 243(6):515\u2013520","journal-title":"J Intern Med"},{"key":"2137_CR85","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/ng0894-451","volume":"7","author":"G Romeo","year":"1994","unstructured":"Romeo G, McKusick V (1994) Phenotypic diversity, alleic series and modifier genes. Nat.Genet 7:451\u2013453","journal-title":"Nat.Genet"},{"issue":"6C","key":"2137_CR86","first-page":"4841","volume":"20","author":"A Russo","year":"2000","unstructured":"Russo A, Zanna I, Tubiolo C, Migliavacca M, Bazan V, Latteri MA, Tomasino RM, Gebbia N (2000) Hereditary common cancers: molecular and clinical genetics. Anticancer Res 20(6C):4841\u20134851","journal-title":"Anticancer Res"},{"issue":"4","key":"2137_CR87","first-page":"1426","volume":"61","author":"D Salvatore","year":"2001","unstructured":"Salvatore D, Melillo RM, Monaco C, Visconti R, Fenzi G, Vecchio G, Fusco A, Santoro M (2001) Increased in vivo phosphorylation of ret tyrosine 1062 is a potential pathogenetic mechanism of multiple endocrine neoplasia type 2B. Cancer Res 61(4):1426\u20131431","journal-title":"Cancer Res"},{"issue":"9","key":"2137_CR88","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1136\/jmg.40.9.714","volume":"40","author":"M Sancandi","year":"2003","unstructured":"Sancandi M, Griseri P, Pesce B, Patrone G, Puppo F, Lerone M, Martucciello G, Romeo G, Ravazzolo R, Devoto M, Ceccherini I (2003) Single nucleotide polymorphic alleles in the 5\u2032 region of the RET proto-oncogene define a risk haplotype in Hirschsprung\u2019s disease. J Med Genet 40(9):714\u2013718","journal-title":"J Med Genet"},{"issue":"5","key":"2137_CR89","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1530\/eje.0.1330513","volume":"133","author":"M Santoro","year":"1995","unstructured":"Santoro M, Grieco M, Melillo RM, Fusco A, Vecchio G (1995) Molecular defects in thyroid carcinomas: role of the RET oncogene in thyroid neoplastic transformation. Eur J Endocrinol 133(5):513\u2013522","journal-title":"Eur J Endocrinol"},{"issue":"Pt 19","key":"2137_CR90","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1242\/jcs.00786","volume":"116","author":"H Sariola","year":"2003","unstructured":"Sariola H, Saarma M (2003) Novel functions and signalling pathways for GDNF. J Cell Sci 116(Pt 19):3855\u20133862","journal-title":"J Cell Sci"},{"issue":"6","key":"2137_CR91","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/110241501750243851","volume":"167","author":"Y Sasaki","year":"2001","unstructured":"Sasaki Y, Shimotake T, Go S, Iwai N (2001) Total thyroidectomy for hereditary medullary thyroid carcinoma 12\u00a0years after correction of Hirschsprung\u2019s disease. Eur J Surg 167(6):467\u2013469","journal-title":"Eur J Surg"},{"key":"2137_CR92","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/archpedi.1957.04030030079012","volume":"94","author":"E Schocket","year":"1957","unstructured":"Schocket E, Telok HA (1957) Aganglionic megacolon, phaeochromocytoma, megaloureter and neurofibromatosis. Am J Dis Child 94:185\u2013191","journal-title":"Am J Dis Child"},{"key":"2137_CR93","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/367380a0","volume":"367","author":"A Schuchardt","year":"1994","unstructured":"Schuchardt A, D\u2019Agati V, Larsson-Blomberg L, Constanini F, Pachnis V (1994) Defects in the kidney and enteric system of mice lacking the tyrosine- kinase receptor ret. Nature 367:380\u2013383","journal-title":"Nature"},{"key":"2137_CR94","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/archpedi.1957.04030030079012","volume":"94","author":"E Shocket","year":"1957","unstructured":"Shocket E, Teloh HA (1957) Aganglionic megacolon, phaeochromocytoma, megaloureter and neurofibromatosis. Am J Dis Child 94:185\u2013191","journal-title":"Am J Dis Child"},{"issue":"4","key":"2137_CR95","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/gut.43.4.542","volume":"43","author":"RH Sijmons","year":"1998","unstructured":"Sijmons RH, Hofstra RM, Wijburg FA, Links TP, Zwierstra RP, Vermey A, Aronson DC, Tan-Sindhunata G, Brouwers-Smalbraak GJ, Maas SM, Buys CH. (1998) Oncological implications of RET gene mutations in Hirschsprung\u2019s disease. Gut 43(4):542\u2013547","journal-title":"Gut"},{"issue":"6130","key":"2137_CR96","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/328528a0","volume":"328","author":"NE Simpson","year":"1987","unstructured":"Simpson NE, Kidd KK, Goodfellow PJ, McDermid H, Myers S, Kidd JR, Jackson CE, Duncan AM, Farrer LA, Brasch K (1987) Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by linkage. Nature 328(6130):528\u2013530","journal-title":"Nature"},{"key":"2137_CR97","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0002-9343(61)90234-0","volume":"31","author":"JH Sipple","year":"1961","unstructured":"Sipple JH (1961) The association of phaeochromocytomas with carcinomas of the thyroid gland. Am J Med 31:163\u2013166","journal-title":"Am J Med"},{"issue":"12","key":"2137_CR98","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s00383-006-1785-6","volume":"22","author":"R Skaba","year":"2006","unstructured":"Skaba R, Dvorakova S, Vaclavikova E, Vlcek P, Frantlova M, Bendlova B (2006) The risk of medullary thyroid carcinoma in patients with Hirschsprung\u2019s disease. Pediatr Surg Int 22(12):991\u2013995","journal-title":"Pediatr Surg Int"},{"issue":"2","key":"2137_CR99","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0960-7404(03)00033-1","volume":"12","author":"MA Skinner","year":"2003","unstructured":"Skinner MA (2003) Management of hereditary thyroid cancer in children. Surg Oncol 12(2):101\u2013104","journal-title":"Surg Oncol"},{"key":"2137_CR100","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/00005792-196809000-00001","volume":"47","author":"AL Steiner","year":"1968","unstructured":"Steiner AL, Goodman AD, Powers SR (1968) Study of a kindred with phaeochromocytoma, medullary thyroid carcinoma, hyperparathyroidism, and Cushings disease:multiple endocrine neoplasia. Medicine (Baltimore) 47:371\u2013409","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"2137_CR101","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0092-8674(85)90115-1","volume":"42","author":"M Takahashi","year":"1985","unstructured":"Takahashi M, Ritz J, Cooper GM (1985) Activation of a novel human transforming gene, ret, by DNA rearrangement. Cell 42(2):581\u2013588","journal-title":"Cell"},{"issue":"4","key":"2137_CR102","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/(SICI)1098-1004(1999)13:4<331::AID-HUMU11>3.0.CO;2-#","volume":"13","author":"M Takahishi","year":"1999","unstructured":"Takahishi M, Iwashita T, Santoro M, Lyonnet S, Lenoir GM, Billaud M (1999) Co-segregation of MEN2 and Hirschsprung\u2019s disease: the same mutation with both gain and loss of function. Hum Mutat 13(4):331\u2013336","journal-title":"Hum Mutat"},{"key":"2137_CR103","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1590\/S1807-59322006000100011","volume":"61","author":"SPA Toledo","year":"2006","unstructured":"Toledo SPA, Cortina MA, Toledo RA et al (2006) Impact of RET protooncogene analysis on the clinical management of multiple endocrine neoplasia type 2. Clinics 61:59\u201370","journal-title":"Clinics"},{"issue":"5\u20136","key":"2137_CR104","first-page":"378","volume":"18","author":"M Torre","year":"2002","unstructured":"Torre M, Martucciello G, Ceccherini I, Lerone M, Aicardi M, Gambini C, Jasonni V. (2002) Diagnostic and therapeutic approach to multiple endocrine neoplasia type 2B in pediatric patients. Pediatr Surg Int 18(5\u20136):378\u2013383","journal-title":"Pediatr Surg Int"},{"issue":"6461","key":"2137_CR105","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/367319a0","volume":"367","author":"V Heyningen van","year":"1994","unstructured":"van Heyningen V (1994) Genetics. One gene\u2013four syndromes. Nature 367(6461):319\u2013320","journal-title":"Nature"},{"issue":"4","key":"2137_CR106","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/00005176-198212000-00027","volume":"1","author":"M Verdy","year":"1982","unstructured":"Verdy M, Weber AM, Roy CC, Morin CL, Cadotte M, Brochu P. (1982) Hirschsprung\u2019s disease in a family with multiple endocrine neoplasia type 2. J Pediatr Gastroenterol Nutr 1(4):603\u2013607","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2137_CR107","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/path.1700910109","volume":"91","author":"ED Williams","year":"1966","unstructured":"Williams ED, Pollock DJ (1966) Multiple mucosal neuromata with endocrine tumours:a syndrome allied to von Recklinghausens disease. J Pathol Bacteriol 91:71\u201380","journal-title":"J Pathol Bacteriol"},{"issue":"21","key":"2137_CR108","doi-asserted-by":"crossref","first-page":"9661","DOI":"10.1128\/MCB.25.21.9661-9673.2005","volume":"25","author":"A Wong","year":"2005","unstructured":"Wong A, Bogni S, Kotka P, de Graaff E, D\u2019Agati V, Costantini F, Pachnis V (2005) Phosphotyrosine 1062 is critical for the in vivo activity of the Ret9 receptor tyrosine kinase isoform. Mol Cell Biol 25(21):9661\u20139673","journal-title":"Mol Cell Biol"},{"issue":"4","key":"2137_CR109","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/archsurg.138.4.409","volume":"138","author":"L Yip","year":"2003","unstructured":"Yip L, Cote GJ, Shapiro SE, Ayers GD, Herzog CE, Sellin RV, Sherman SI, Gagel RF, Lee JE, Evans DB (2003) Multiple endocrine neoplasia type 2: evaluation of the genotype\u2013phenotype relationship. Arch Surg 138(4):409\u2013416","journal-title":"Arch Surg"}],"container-title":["Pediatric Surgery International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00383-008-2137-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00383-008-2137-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00383-008-2137-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T15:52:09Z","timestamp":1559058729000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00383-008-2137-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,26]]},"references-count":109,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["2137"],"URL":"https:\/\/doi.org\/10.1007\/s00383-008-2137-5","relation":{},"ISSN":["0179-0358","1437-9813"],"issn-type":[{"value":"0179-0358","type":"print"},{"value":"1437-9813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,26]]}}}